Drug application
IMIPENEM AND CILASTATIN (CILASTATIN SODIUM, IMIPENEM)
Drugs@FDA ANDA 090577 · ACS DOBFAR
Key facts
| Drug name | IMIPENEM AND CILASTATIN |
|---|---|
| Active ingredients | CILASTATIN SODIUM, IMIPENEM |
| Application type | ANDA |
| Application number | 090577 |
| Company | ACS DOBFAR |
| Dosage forms | POWDER, INTRAVENOUS |
| Strength | EQ 250MG BASE/VIAL;250MG/VIAL |
| Marketing status | Prescription |
| Reference listed drug | No |
| Latest submission status date | Dec 21, 2011 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.